Demo Sign up Log In

Biocryst Pharmaceuticals Inc (BCRX)

Cost of Revenue

$3.84M

Quarterly · Period ending: Jun 30, 2026 · USD

BCRX Cost of Revenue

Latest reported$3.84Mperiod endingJun 30, 2026

Latest reported$3.84Mperiod endingJun 30, 2026

BCRX Quarterly Cost of Revenue ($900.00K → $3.84M)

Quarterly cost of revenue

High-resolution chart · PNG

BCRX cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Biocryst Pharmaceuticals Inc Cost of Revenue — Quarterly (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2001	0
Mar 31, 2001	0
Dec 31, 2000	507,780
Sep 30, 2000	-184,000
Jun 30, 2000	-169,000
Mar 31, 2000	-154,780
Dec 31, 1999	-100,000
Sep 30, 1999	-100,000
Jun 30, 1999	-200,000
Mar 31, 1999	-100,000
Dec 31, 1998	-100,000
Sep 30, 1998	-100,000
Jun 30, 1998	-300,000
Mar 31, 1998	-100,000
Dec 31, 1997	-100,000
Sep 30, 1997	-200,000
Jun 30, 1997	-200,000
Mar 31, 1997	-100,000
Dec 31, 1996	7,500,000
Sep 30, 1996	-100,000
Jun 30, 1996	-200,000
Mar 31, 1996	-100,000
Dec 31, 1995	6,900,000
Sep 30, 1995	-100,000
Jun 30, 1995	-100,000
Mar 31, 1995	-200,000
Dec 31, 1994	1,600,000
Sep 30, 1994	1,300,000
Jun 30, 1994	1,200,000
Mar 31, 1994	900,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.